Kline Blogs Banner
Another Decade of Glyphosate Use Allowed in the European Union

Another Decade of Glyphosate Use Allowed in the European Union

After a regulatory stalemate among member states, the European Commission voted to allow the continued use of glyphosate, a chemical herbicide used as the active ingredient in Roundup, to be sold until 2033. Individual countries can opt to ban the ingredient; however, on the whole, the EU will allow its use on crops and for industrial vegetation management (IVM).

Continue reading

The Role of EPR in the Used Oil Value Chain

The Role of EPR in the Used Oil Value Chain

To date ‘Extended Producer Responsibility’ (EPR) schemes relating to lubricants and waste oil have been introduced in more than 60 countries, including a dozen in Europe formed under the auspices of EU Waste Directives, starting with Italy in 1982. But relatively few of the current used oil EPR schemes have caused material improvements in waste oil regeneration. There is no standard EPR model; each is different. But they adhere to one of four fundamental principles:

Continue reading

Blowouts on the Rise Despite the Overall Downturn in Salon Services

Blowouts on the Rise Despite the Overall Downturn in Salon Services

Inflation has cast its shadow over various consumer categories and retail services over the past two years. Hair salons, too, have been facing the same pressure. According to U.S. data from Kline PRO, covering the past four quarters through Q2 2023, the overall number of services sold at independent hair salons has been in decline, with elevated pricing holding revenue about flat.

Continue reading

ABIM 2023 A Glimpse into the Future of Biocontrol

ABIM 2023: A Glimpse Into the Future of Biocontrol

The Agricultural Biologicals Industry Meeting (ABIM) 2023, a vibrant event where the future of biocontrol solutions came into focus, has recently concluded in Basel, Switzerland. This annual global gathering serves as a critical platform for delving into the key role that biocontrol plays in revolutionizing plant protection and ensuring the sustainability of food and farming. It featured insightful presentations, innovative ideas, and a wide range of exhibitors—including key players such as Syngenta, BASF, and Valent—showcasing nature-based solutions.

Continue reading

Five Facts You Should Know About Today’s Beauty Indies

Five Facts You Should Know About Today’s Beauty Indies

The vibrancy of the indie beauty scene has continued in 2023, with sales up 90% versus 2022, according to Kline’s recently published Beauty Indies: U.S. Analysis of Brands to Watch in partnership with NielsenIQ. This year, growth in this sector has outpaced the total industry more than tenfold, which is a result of retailer support and brands’ purpose-driven efforts, accessible pricing, and innovation that spans product development, brand messaging, and digital marketing.

Continue reading

Saudi Arabia, the UAE, and Kuwait's Firm Commitment to Electrification and Sustainability

Saudi Arabia, the UAE, and Kuwait’s Firm Commitment to Electrification and Sustainability

Countries across the Middle East are in the middle of a sweeping economic transformation. Governments are seeking to diversify their economy, turning away from oil and gas dependency to develop broader, more versatile economies. From Kuwait to the United Arab Emirates (UAE), ambitious plans are being rolled out to develop new industries and markets, with sustainability and greener, environment-friendly alternatives to fossil fuels at their core, as unveiled in our latest research on the lubricants market in the Middle East.

Continue reading

Excipients for Parenteral Pharmaceuticals Set to Grow, but Specialization Is Key

Excipients for Parenteral Pharmaceuticals Set to Grow, But Specialization Is Key

While oral administration remains the most preferred drug delivery method worldwide, the parenteral route plays a crucial role in global healthcare due to its ability to bypass the digestive system. According to our report, the global parenteral pharmaceutical market is projected to grow at a remarkable 7.5% rate over the next five years, surpassing the average industry growth in pharmaceuticals. This rise is driven by the increasing FDA approvals of parenteral new molecular entities (NMEs), primarily in the field of oncology, along with steadily rising in infectious diseases, cardiovascular, and diabetes treatment.

Continue reading